IMMUNOLOGICAL ACTIVATION DURING PREGNANCY - SERIAL MEASUREMENT OF LYMPHOCYTE PHENOTYPE AND SERUM ACTIVATION MOLECULES IN HIV-INFECTED AND UNINFECTED WOMEN
Y. Mikyas et al., IMMUNOLOGICAL ACTIVATION DURING PREGNANCY - SERIAL MEASUREMENT OF LYMPHOCYTE PHENOTYPE AND SERUM ACTIVATION MOLECULES IN HIV-INFECTED AND UNINFECTED WOMEN, Journal of reproductive immunology, 33(2), 1997, pp. 157-170
Immunologic alterations occur during pregnancy, but the effect of preg
nancy on HIV infection is controversial. We characterized some of the
immunologic alterations with potential to influence HIV disease in 99
infected and 46 uninfected women during pregnancy and up to 6 months p
ost-partum. Immunophenotyping to quantitate the major lymphocyte subse
ts and determine expression of activation and adhesion molecules on T
cells was performed using 3-color staining and laser flow cytometry. S
erum neopterin, beta 2-microglobulin, and tumor necrosis factor-alpha
(TNF alpha) were quantitated using commercial immunoassays. HIV+ pregn
ant women were compared to uninfected pregnant subjects and to referen
ce ranges established on healthy, HIV-seronegative non-pregnant female
controls. Both CD4 and CD8 T cell subsets were increased in HIV-negat
ive pregnant women compared to non-pregnant controls. In HIV-infected
pregnant women, CD4 T cells were low and CD8 cells were elevated compa
red to HIV-negative pregnant and non-pregnant women. Levels of subsets
were stable during pregnancy and postpartum in both groups of women.
Evidence of peripheral immune activation was found during the later st
ages of pregnancy. Increases in HLA-DR and CD38 activation antigens on
CD8 cells, serum neopterin and beta-2-microglobulin were seen during
pregnancy in HIV-negative women. These correlates of immune activation
were increased in HIV-infected pregnant women and increased further d
uring pregnancy, paralleling changes seen in uninfected pregnant women
. These immunologic alterations may directly or indirectly enhance vir
al replication, impacting the long-term course of HIV disease. (C) 199
7 Elsevier Science Ireland Ltd.